Provided by Tiger Fintech (Singapore) Pte. Ltd.

Embecta Corp.

12.09
+0.09000.75%
Pre-market: 12.300.2100+1.74%05:56 EDT
Volume:931.03K
Turnover:11.19M
Market Cap:702.85M
PE:12.21
High:12.63
Open:11.34
Low:11.34
Close:12.00
Loading ...

Company Profile

Company Name:
Embecta Corp.
Exchange:
NASDAQ
Establishment Date:
1924
Employees:
2100
Office Location:
300 Kimball Drive,Suite 300,Parsippany,New Jersey,United States
Zip Code:
07054
Fax:
- -
Introduction:
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Directors

Name
Position
David F. Melcher
Non-Executive Chairman
Devdatt Kurdikar
Director,President and Chief Executive Officer
Carrie L. Anderson
Director
Christopher R. Reidy
Director
Claire Pomeroy
Director
David J. Albritton
Director
Karen N. Prange
Director
Milton M. Morris
Director
Robert J. Hombach
Director

Shareholders

Name
Position
Devdatt Kurdikar
Director,President and Chief Executive Officer
Ajay Kumar
Senior Vice President and Chief Human Resources Officer
Colleen Riley
Senior Vice President and Chief Technology Officer
Ginny Blocki
Senior Vice President, Product Management and Global Marketing
Jacob Elguicze
Senior Vice President and Chief Financial Officer
Jeff Mann
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
Shaun Curtis
Senior Vice President, Global Manufacturing and Supply Chain
Slobodan Radumilo
Senior Vice President and President, International
Tom Blount
Senior Vice President and President, North America
Brian Capone
Vice President, Chief Accounting Officer and Corporate Controller